It is a business services private limited company based in Nashik, Maharashtra, India, established in 2023.
2023 | Nashik, Maharashtra, India | ActiveSuryoday Cancer And Research Private Limited, a active private limited company, was established on 11 April 2023 in Nashik, Maharashtra, India. it holds CIN: U86100MH2023PTC400578. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Bhushan Manohar Nikam (Director), Sonal Bhushan Nikam (Director), Satish Ramkrishna Sonawane (Director). It holds ₹8.00 Cr open charges and no settled loans. Its latest AGM occurred on 06 December 2024, with the balance sheet filed on 31 March 2024. It is based at Sr.No.699/1/3, Flat No.401,, Cerscent Apartment, Nashik, Nashik, Maharashtra, 422005.
U86100MH2023PTC400578
400578
11 April 2023
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Suryoday Cancer And Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhushan Manohar Nikam | Director | 11 Apr 2023 | Current |
| Sonal Bhushan Nikam | Director | 11 Apr 2023 | Current |
| Satish Ramkrishna Sonawane | Director | 11 Apr 2023 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Suryoday Cancer And Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Suryoday Cancer And Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹80,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Apr 2025 | Others | ₹1.50 Cr | Open |
| 08 Apr 2024 | Others | ₹6.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Suryoday Cancer And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Suryoday Cancer And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suryoday Cancer And Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 15.00 M with Charge ID 101092386 was registered on 28 Apr 2025. was recorded as a recent event.
The activity Suryoday Cancer And Research Private Limited last Annual general meeting of members was held on 06 Dec 2024 as per latest MCA records. was completed.
Progress on A charge with Others amounted to Rs. 65.00 M with Charge ID 100905062 was registered on 08 Apr 2024. was documented.
Suryoday Cancer And Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Bhushan Manohar Nikam was appointed as a Director was appointed as a Director on 11 Apr 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The activity Sonal Bhushan Nikam was appointed as a Director was appointed as a Director on 11 Apr 2023 & has been associated with this company since 2 years 7 months . was completed.
The CIN of Suryoday Cancer And Research Private Limited is U86100MH2023PTC400578.
Suryoday Cancer And Research Private Limited is headquartered at Sr.No.699/1/3, Flat No.401,, Cerscent Apartment, Nashik, Nashik, Maharashtra, 422005.
Suryoday Cancer And Research Private Limited was incorporated on 11 April 2023.
The current directors of Suryoday Cancer And Research Private Limited are
Suryoday Cancer And Research Private Limited is unlisted.
The authorized capital of Suryoday Cancer And Research Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX